||EPS - Basic
||Market Cap (m)
|Health Care Equipment & Services
Ekf Diagnostics Share Discussion Threads
Showing 1376 to 1398 of 1400 messages
|7th Feb 2017
EKF's new Procalcitonin (PCT) study shows that testing reduces hospital costs and length of stay.
Sepsis carries a huge economic and human cost affecting over 27,000,000 people per year, and resulting in over 8,000,000 deaths per year 2. The USA spend over $20 billion dollars per year on sepsis care, so finding a way to screen and treat patients in the fastest, safest and most cost effective way is right at the top of many hospital agendas.
The EKF Diagnostics Procalcitonin LiquiColor® Test is a marker for bacterial infection and sepsis and can be used as a quick ten minute test, in conjunction with other tests, to quickly assess initial severity of sepsis. The test is CE marked and currently going through the FDA approval process. It is an open-channel test that can provide a cost effective solution for many hospital labs.
Full release - https://www.ekfdiagnostics.com/news.html|
|Well it looked like a very large 'cross' yesterday. (12m+)The amount on the buy side seems to equate to an amount that should be disclosed, so let's see. The price was below the then market too.|
|For the last couple of weeks there has been some relatively large individual trades reported (2m, 5m, 6m, 7m, 8m and 13m etc) all at the same price, so accordingly I would expect to see some holding announcements. If the Chairman has picked any of them up it could get quite interesting!|
|Some congratulations are in order. A good update|
|Does anyone have access to a recent brokers note on EKF? would appreciate a look.
Best regards SBP|
|Quite some turnaround at EKF, which looks set to continue with the current management making it happen!|
|Due for another tick up soon according to charts|
|Hi butchdogg nice to see you here, great company on the mend Flx is breaking out|
|this just popped up on a scan.. looks interesting. Hi Hamid i see you over on the FLX thread too.|
|Recent pound weakness post Brexit will be helping the figures as well. A bit of luck perhaps|
|Further to my post 1153 on 5th. October, I'm very pleased that the expected re-rating has come as soon as it has. Here's to the future ... :)|
|Business is booming that they had to revise expectations after 4 weeks again and all the growth is organic. Brilliant|
|NS Number : 4295OEKF Diagnostics Holdings PLC07 November 2016EKF Diagnostics Holdings plc("EKF", the "Company")Trading updateEKF Diagnostics Holdings plc (AIM: EKF), the AIM listed point-of-care business, announces that early trading in Q4 of the current financial year has again been materially higher than budget and at a run-rate in excess of already revised market forecasts, upgraded following the trading update provided on 7 October 2016.The Company now believes that it will achieve revenues of at least GBP36.5m and adjusted EBITDA for the year ending 31 December 2016 of at least GBP5.5m, therefore exceeding current market forecasts. The strong performance of the business is due to organic growth.In addition, the Company announces that cash generation continues to be strong and now expects to be close to breakeven if not cash positive by the year end, and then cash positive in the first quarter, again ahead of the board's previous expectations.|
|Wow that's a cracking update again|
|Still not sure how this business is worth £60m+ (even in a recovery phase). It feels like you are paying up for profits which may never materialise again... Even if it becomes cash positive, when will shareholders see REAL earnings?
Can anyone enlighten me?|
|Nice to see that this focused POC play is now yielding the benefits, with trading materially higher than budget and in excess of market forecasts.|
Buffet made one of the biggest losses in his company's history US$444m, when he sold however many he did.had he done so today, he would have lost a great deal more. Morningstar data is not listing his company as a major holder today.|
|Buffet selling Tesco was his mistake: it's a turnaround situation now coming good. The 10%+ rise today is a good sign, to say the least. EKF, I agree, is a buy and hold for future returns; and the current price is a good entry point, IMHO.|
|Az. Sure. And Tesco is a case in point. Lots of people got a surprise when some of their hidden accounting practises came to light. It took a whistle blower to point them out. I'm just trying to point out that headline numbers when expressed in certain ways can be deceiving. The track record so far for EKF is not great despite much promise. Now they are meant to be on firmer ground with a clear sight of the goals (if not the end of the tunnel) but there is a notable absence of activity in the share price going north, or newsflow come to that, to underline these favourable expectations.|
|For all Buffets skills, he admitted making a mistake investing in Tesco and sold at a loss. No one, not even the Sage gets it right all the time.|
|Buffet might not get to actually invest in companies if some investors did not back the companies that might go on be the types he then invests in.
EKF is a pure POC testing play now which should yield much improvement. It will probably never meet Buffets investment criteria............as it will likely be bought out long before that!|
|I'm no accountant but i posted the Buffet comments here because EKF always bangs on about EBITDA figures and its's a lesson for us all. Google defines "Earnings before interest, tax, depreciation and amortization (EBITDA) is a measure of a company's operating performance. Essentially, it's a way to evaluate a company's performance without having to factor in financing decisions, accounting decisions or tax environments"
If you're borrowing money you have to pay interest, if you're making profits you have to pay tax. If you're investing in R&D or plant and machinery (german production) then you will have to treat those investments with Depreciation and Amortization. EKF is doing all this in spades, You can be posting lovely EBITDA figures year on year but these other factors can screw you up. BEWARE|
|So, which statistic/s can one trust, Ptx profits, revenues; if these are reported to have risen, would that not mean Eps must have also risen?|